Getinge to boost scalability and deepen healthcare access in India
Getinge has a strong market share in India within several product segments
Getinge has a strong market share in India within several product segments
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
India has a pivotal role in eliminating TB
Integration of modern and traditional medicine to facilitate the illness to wellness journey
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Receives regulatory approval for its molecule ‘Selumetinib’ in India
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
New subgroup analysis from Phase III ARASENS trial shows that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel increased overall survival (OS)
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
Subscribe To Our Newsletter & Stay Updated